Results 261 to 270 of about 619,857 (348)

Biomarkers Reflecting the Severity of Bronchial Asthma in Children. [PDF]

open access: yesJ Asthma Allergy
Kunc P   +6 more
europepmc   +1 more source

Fungal‐Driven Airways Dis‐Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and Differences. An EAACI Task Force Report

open access: yesAllergy, Volume 80, Issue 12, Page 3274-3289, December 2025.
ABSTRACT Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) do not rarely coexist and share several similarities in terms of pathobiological background, together with overlapping clinical manifestations, misleading the correct diagnosis. Within that scenario, severe asthma with fungal sensitization (SAFS) further complicates the correct ...
Marco Caminati   +10 more
wiley   +1 more source

Patient education in bronchial asthma: analysis of feedback from parents

open access: diamond, 2018
Sunil Taneja   +3 more
openalex   +2 more sources

Real‐Life Clinical Experience With SQ Grass, Tree, Ragweed, and House Dust Mite Sublingual Immunotherapy Tablets: A Review of Evidence From Non‐Interventional Studies

open access: yesAllergy, Volume 80, Issue 12, Page 3290-3301, December 2025.
ABSTRACT This review evaluates data from > 12,000 children, adolescents and adults (≥ 4 years) in non‐interventional studies to assess the real‐life effectiveness and safety of SQ sublingual immunotherapy (SLIT)‐tablets for allergic rhinitis (AR).
Oliver Pfaar   +4 more
wiley   +1 more source

Diversity and Dosage Determine the Efficacy of the Probiotic SYN‐53 in Allergic Rhinoconjunctivitis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

open access: yesAllergy, Volume 80, Issue 12, Page 3310-3318, December 2025.
The probiotic food supplement SYN‐53 has previously shown efficacy in managing allergic rhinoconjunctivitis (ARC), with its high bacterial diversity and dosage hypothesized as key drivers. This study on 166 subjects aimed to confirm this hypothesis by comparing the effects of SYN‐53, a low dose variant (SYN‐53‐LD), a low diversity variant (SYN‐4), and ...
Karl‐Christian Bergmann   +1 more
wiley   +1 more source

Oxidative Stress and Risk Factors in Adult Patients with Bronchial Asthma: A Clinical Analysis of Representative Biomarkers. [PDF]

open access: yesJ Clin Med
Melinte OE   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy